Admission Date:  [**2103-7-9**]              Discharge Date:   [**2103-8-3**]  Date of Birth:  [**2024-12-10**]             Sex:   M  Service: MEDICINE  Allergies: Allopurinol / Ciprofloxacin  Attending:[**First Name3 (LF) 30**] Chief Complaint: Severe Rash   Major Surgical or Invasive Procedure: 1.
History of Present Illness: 78 yo M with ESRD, HTN, hyperlipidemia, MGUS who presents with an approximately 7-day h/o desquamative rash that he states began after taking an antibiotic prescribed in [**Country 3594**].
He was reportedly diagnosed with a URI and given an antibiotic (unsure of which) as well as tylenol.
Of note, MR. [**Known lastname **] had diffuse skin flaking noted after starting allopurinol [**2102**].
He was given 30cc of kayexalate for K=5.7, IV fluids for mild dehydration, and a dermatology consultation was obtained.
-anemia -hypertension -hyperlipidemia -gout.
Neuro: MS [**First Name (Titles) **] [**Last Name (Titles) **], CN II-XII in tact, UE/LE strength 5+ bilaterally ([**Last Name (Titles) **] limited by discomfort from rash)  Pertinent Results: [**2103-7-8**] 11:15PM   PLT COUNT-358# [**2103-7-8**] 11:15PM   NEUTS-70.0 LYMPHS-17.4* MONOS-5.0 EOS-7.5* BASOS-0.1 [**2103-7-8**] 11:15PM   WBC-8.7 RBC-3.98* HGB-11.8* HCT-35.8* MCV-90# MCH-29.6 MCHC-33.0 RDW-17.3* [**2103-7-8**] 11:15PM   GLUCOSE-120* UREA N-64* CREAT-6.7*# SODIUM-135 POTASSIUM-5.7* CHLORIDE-98 TOTAL CO2-21* ANION GAP-22 [**2103-7-8**] 11:20PM URINE  [**Month/Day/Year 3143**]-SM NITRITE-NEG PROTEIN-100 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-0.2 PH-7.0 LEUK-NEG [**2103-7-8**] 11:20PM URINE  RBC-0 WBC-0 BACTERIA-RARE YEAST-NONE EPI-0 [**2103-7-8**] 11:20PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-<=1.005 [**2103-7-8**] 11:27PM   LACTATE-2.8* [**2103-7-9**] 04:40AM   WBC-6.7 RBC-3.53* HGB-10.5* HCT-31.6* MCV-90 MCH-29.7 MCHC-33.2 RDW-17.3* [**2103-7-9**] 04:40AM   calTIBC-246* FERRITIN-504* TRF-189* [**2103-7-9**] 04:40AM   ALBUMIN-3.6 CALCIUM-9.2 PHOSPHATE-5.1* MAGNESIUM-2.1 IRON-18* [**2103-7-9**] 04:40AM   LIPASE-46 [**2103-7-9**] 04:40AM   ALT(SGPT)-26 AST(SGOT)-26 ALK PHOS-75 AMYLASE-200* TOT BILI-0.5 .
Skin, left ankle, punch (A-B): Subepidermal bullae with hyperkeratosis, parakeratosis, scattered dyskeratotic keratinocytes, and a lichenoid lymphohistiocytic inflammatory infiltrate (see note).
Negative Cultures: [**2103-7-27**] JOINT FLUID GRAM STAIN-FINAL; FLUID CULTURE-No Growth [**2103-7-26**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-PENDING; ANAEROBIC BOTTLE-PENDING [**2103-7-26**] URINE URINE CULTURE-FINAL [**2103-7-26**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-PENDING; ANAEROBIC BOTTLE-PENDING [**2103-7-25**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-PENDING; ANAEROBIC BOTTLE-PENDING [**2103-7-24**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-PENDING; ANAEROBIC BOTTLE-PENDING [**2103-7-24**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-PENDING; ANAEROBIC BOTTLE-PENDING [**2103-7-20**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-19**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-18**] DIRECT ANTIGEN TEST FOR VARICELLA-ZOSTER VIRUS DIRECT ANTIGEN TEST FOR VARICELLA-ZOSTER VIRUS-FINAL; Direct Antigen Test for Herpes Simplex Virus Types 1 & 2-FINAL [**2103-7-19**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-18**] SWAB VIRAL CULTURE: R/O HERPES SIMPLEX VIRUS-FINAL; VARICELLA-ZOSTER CULTURE-PRELIMINARY [**2103-7-16**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-15**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-15**] STOOL FECAL CULTURE-FINAL; CAMPYLOBACTER CULTURE-FINAL; OVA + PARASITES-FINAL; O&P MACROSCOPIC [**Month/Day/Year **] - WORM-FINAL; CLOSTRIDIUM DIFFICILE TOXIN ASSAY-FINAL [**2103-7-15**] SCOTCH TAPE PREP/PADDLE SCOTCH TAPE PREP/PADDLE-FINAL [**2103-7-14**] URINE URINE CULTURE-FINAL [**2103-7-14**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-14**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-13**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-13**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-12**] URINE URINE CULTURE-FINAL [**2103-7-12**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-12**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-9**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-8**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-8**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL [**2103-7-8**] URINE URINE CULTURE-FINAL .
Cultures that grew bacteria: [**2103-7-24**] CATHETER TIP-IV WOUND CULTURE-FINAL {ACINETOBACTER BAUMANNII} [**2103-7-15**] SWAB GRAM STAIN-FINAL; WOUND CULTURE-FINAL {YEAST, PRESUMPTIVELY NOT C. ALBICANS}; ANAEROBIC CULTURE-FINAL {PREVOTELLA SPECIES} [**2103-7-16**] [**Month/Day/Year 3143**] CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL {STAPHYLOCOCCUS, COAGULASE NEGATIVE} .
IV catheter tip cx: acinetobacter baumannii ([**Last Name (un) 36**] to cefepime, gent, zosyn and tobra.
The left kidney measures approximately 8.0 cm.
Brief Hospital Course: Mr. [**Known lastname **] is a 78 year-old male with ESRD, HTN, hyperlipidemia, MGUS who presented with Erythema multiform/[**Doctor First Name **]-[**Known lastname **] syndrome after taking allopurinol presumably.
He was managed on the floor in a supportive manner with fluids, empiric antibiotics, and wound care.
Patient was treated with 7 days of cefepime for a line infection.
Finally, he developed an acute gouty flare treated with colchicine, oxycodone, and prednisone.
No IgG or steroids were started as the patient presented past the window during which time this is found to be a useful intervention.
On the floor insensible losses were tremendous and he recieved aggressive IVF.
Wound care was managed with xeroform and bactroban.
ID service recommended broad empiric antibiotics given travel hx and very complicated patient.
Pt was started on meropenem and vancomycin.
Skin care with bactroban and xeroform continued throughout the hospitalization and the dry intact skin was moistened with aquaphor.
He was well rate controlled with toprol XL 200.
Diltiazem 30 mg po qid was started [**2103-8-1**] for improved rate control, as patient was running in the 90s.
Coagulation was held initially due to dysphagia and concern for mucosal involvement and bleed risk.
On [**7-24**], heparin and coumadin were intiated with a goal of INR [**3-1**].
He continued to have pain, and thus po prednisone and oxycontin/oxycodone were added.
Medications on Admission: Meds on admission: Atenolol 100 Amlodipine 10 Lipitor 20 Lasix 40 (was started on gout regimen including colchicine prior to going to [**Country 3594**], which he discontinued shortly after leaving [**Location (un) 86**]).
Erythromycin 5 mg/g Ointment Sig: [**1-28**] gtt Ophthalmic  QID (4 times a day).
Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Mineral Oil-Hydrophil Petrolat     Ointment Sig: One (1) Appl Topical  QD ().
Mupirocin Calcium 2 % Cream Sig: One (1) Appl Topical  [**Hospital1 **] (2 times a day).
Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.)
Camphor-Menthol 0.5-0.5 % Lotion Sig: One (1) Appl Topical  Q 6HRS () as needed for PRN pruritis.
Metoprolol Succinate 100 mg Tablet Sustained Release 24HR Sig: Two (2) Tablet Sustained Release 24HR PO DAILY (Daily).
Oxycodone 5 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours) as needed for knee pain.
Oxycodone 20 mg Tablet Sustained Release 12HR Sig: One (1) Tablet Sustained Release 12HR PO Q12H (every 12 hours).
Diltiazem HCl 30 mg Tablet Sig: One (1) Tablet PO QID (4 times a day).
Colchicine 0.6 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Epogen 10,000 unit/mL Solution Sig: One (1) injection Injection qMon,Wed,Fri.
Prednisone 10 mg Tablet Sig: 1-2 Tablets PO once a day for 3 days: Taper as follows: [**8-4**] = 20 mg po qd, [**8-5**] = 10 mg po qd, [**8-6**] = 10 mg po qd.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Insulin Regular Human 100 unit/mL Solution Sig: One (1) injection Injection four times a day: please follow attached sliding scale.
Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day.
You should also NOT take VANCOMYCIN or CIPROFLOXACIN, as these medications may also have been involved in starting or worsening the rash.
You have been started on a medication called coumadin.
Coumadin thins your [**Last Name (LF) **], [**First Name3 (LF) **] it is important that you take precautions to avoid bleeding.
